Logo image of MDAI

SPECTRAL AI INC (MDAI) Stock Fundamental Analysis

NASDAQ:MDAI - Nasdaq - US84757T1051 - Common Stock - Currency: USD

1.27  +0.02 (+1.6%)

Premarket: 1.27 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to MDAI. MDAI was compared to 191 industry peers in the Health Care Equipment & Supplies industry. MDAI has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, MDAI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MDAI has reported negative net income.
MDAI had a negative operating cash flow in the past year.
MDAI had negative earnings in 4 of the past 5 years.
In the past 5 years MDAI always reported negative operating cash flow.
MDAI Yearly Net Income VS EBIT VS OCF VS FCFMDAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

With a Return On Assets value of -126.62%, MDAI is not doing good in the industry: 85.34% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -126.62%
ROE N/A
ROIC N/A
ROA(3y)-41.51%
ROA(5y)-25.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDAI Yearly ROA, ROE, ROICMDAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

MDAI has a worse Gross Margin (44.87%) than 63.35% of its industry peers.
The Profit Margin and Operating Margin are not available for MDAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MDAI Yearly Profit, Operating, Gross MarginsMDAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

MDAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
MDAI has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, MDAI has a worse debt to assets ratio.
MDAI Yearly Shares OutstandingMDAI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
MDAI Yearly Total Debt VS Total AssetsMDAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

MDAI has an Altman-Z score of -4.67. This is a bad value and indicates that MDAI is not financially healthy and even has some risk of bankruptcy.
MDAI's Altman-Z score of -4.67 is on the low side compared to the rest of the industry. MDAI is outperformed by 65.97% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.67
ROIC/WACCN/A
WACC8.93%
MDAI Yearly LT Debt VS Equity VS FCFMDAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.57 indicates that MDAI may have some problems paying its short term obligations.
With a Current ratio value of 0.57, MDAI is not doing good in the industry: 92.15% of the companies in the same industry are doing better.
A Quick Ratio of 0.55 indicates that MDAI may have some problems paying its short term obligations.
MDAI's Quick ratio of 0.55 is on the low side compared to the rest of the industry. MDAI is outperformed by 91.10% of its industry peers.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.55
MDAI Yearly Current Assets VS Current LiabilitesMDAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.99% over the past year.
MDAI shows a strong growth in Revenue. In the last year, the Revenue has grown by 238.96%.
EPS 1Y (TTM)42.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-86.36%
Revenue 1Y (TTM)238.96%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%43.82%

3.2 Future

MDAI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.14% yearly.
MDAI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.73% yearly.
EPS Next Y32.91%
EPS Next 2Y21.07%
EPS Next 3Y7.46%
EPS Next 5Y19.14%
Revenue Next Year-24.49%
Revenue Next 2Y23.68%
Revenue Next 3Y45.08%
Revenue Next 5Y17.73%

3.3 Evolution

MDAI Yearly Revenue VS EstimatesMDAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
MDAI Yearly EPS VS EstimatesMDAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.5 -0.5 1 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MDAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MDAI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDAI Price Earnings VS Forward Price EarningsMDAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MDAI Per share dataMDAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.07%
EPS Next 3Y7.46%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MDAI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPECTRAL AI INC

NASDAQ:MDAI (4/24/2025, 8:24:22 PM)

Premarket: 1.27 0 (0%)

1.27

+0.02 (+1.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-27 2025-03-27/amc
Earnings (Next)05-13 2025-05-13/amc
Inst Owners11.68%
Inst Owner Change-0.89%
Ins Owners34.73%
Ins Owner Change0%
Market Cap32.16M
Analysts84
Price Target5.22 (311.02%)
Short Float %6.29%
Short Ratio2.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-91.25%
Min EPS beat(2)-234.97%
Max EPS beat(2)52.47%
EPS beat(4)2
Avg EPS beat(4)-39.11%
Min EPS beat(4)-234.97%
Max EPS beat(4)52.47%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)10.53%
Min Revenue beat(2)8.99%
Max Revenue beat(2)12.08%
Revenue beat(4)3
Avg Revenue beat(4)5.91%
Min Revenue beat(4)-11.4%
Max Revenue beat(4)13.96%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)39.53%
EPS NQ rev (3m)39.53%
EPS NY rev (1m)2.39%
EPS NY rev (3m)19.15%
Revenue NQ rev (1m)28.05%
Revenue NQ rev (3m)28.05%
Revenue NY rev (1m)-13.45%
Revenue NY rev (3m)-13.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.09
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.84
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS1.17
BVpS-0.29
TBVpS-0.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -126.62%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.87%
FCFM N/A
ROA(3y)-41.51%
ROA(5y)-25.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover2.45
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.57
Quick Ratio 0.55
Altman-Z -4.67
F-Score4
WACC8.93%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-86.36%
EPS Next Y32.91%
EPS Next 2Y21.07%
EPS Next 3Y7.46%
EPS Next 5Y19.14%
Revenue 1Y (TTM)238.96%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%43.82%
Revenue Next Year-24.49%
Revenue Next 2Y23.68%
Revenue Next 3Y45.08%
Revenue Next 5Y17.73%
EBIT growth 1Y27.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year51.4%
EBIT Next 3Y46.05%
EBIT Next 5Y20.87%
FCF growth 1Y30.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.52%
OCF growth 3YN/A
OCF growth 5YN/A